ACCPL
Start SIP
Invest Now
Start SIP in ACCPL
Performance
- Low
- ₹88
- High
- ₹90
- 52 Week Low
- ₹54
- 52 Week High
- ₹103
- Open Price₹89
- Previous Close₹90
- Volume20,400
Investment Returns
- Over 1 Month + 8.44%
- Over 3 Month + 37.07%
- Over 6 Month + 22.31%
- Over 1 Year -12.87%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.4
- PEG Ratio
- -
- Market Cap Cr
- 98
- P/B Ratio
- Average True Range
- 4.6
- EPS
- 6.11
- Dividend Yield
- 0
- MACD Signal
- 5.21
- RSI
- 52.65
- MFI
- 67.59
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
Current Price
₹88.00
-1.9
(-2.11%)
- Bearish Moving Average 7
- Bullish Moving Average 7
- 20 Day
- ₹88.26
- 50 Day
- ₹79.69
- 100 Day
- ₹73.83
- 200 Day
- -
Resistance and Support
88.67
- R3 91.33
- R2 90.67
- R1 89.33
- S1 87.33
- S2 86.67
- S3 85.33
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-06-10 | Audited Results & Others | To consider Other business matters. |
Accretion Pharmaceuticals F&O
About Accretion Pharmaceuticals
- NSE Symbol
- ACCPL
- BSE Symbol
- Managing Director
- Mr. Vivek Ashok Kumar Patel
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹88 As on 24 December, 2025 | 21:56
The Market Cap of Accretion Pharmaceuticals is ₹97.8 Cr As on 24 December, 2025 | 21:56
The P/E ratio of Accretion Pharmaceuticals is 14.4 As on 24 December, 2025 | 21:56
The PB ratio of Accretion Pharmaceuticals is 2.1 As on 24 December, 2025 | 21:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.